Dictamnine was the primary active component of DdT, which could regulate the degranulation of mast cells in atopic dermatitis mice (Lin et al., 2021) and ameliorate inflammation in an oxazolone-induced dermatitis mouse model (Huang et al., 2024). This evidence concerns the gene DDT and skin disorder.